TANA, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 2.843
AS - Asia 1.757
EU - Europa 1.684
SA - Sud America 192
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 6
Totale 6.510
Nazione #
US - Stati Uniti d'America 2.780
SG - Singapore 791
CN - Cina 451
IT - Italia 301
IE - Irlanda 239
SE - Svezia 221
RU - Federazione Russa 213
VN - Vietnam 204
BR - Brasile 165
UA - Ucraina 148
GB - Regno Unito 147
DE - Germania 138
TR - Turchia 122
FR - Francia 101
IN - India 78
FI - Finlandia 61
CA - Canada 30
AT - Austria 29
BD - Bangladesh 27
HK - Hong Kong 27
PL - Polonia 20
ES - Italia 17
MX - Messico 17
AR - Argentina 13
IQ - Iraq 11
JP - Giappone 11
LT - Lituania 11
NL - Olanda 9
RO - Romania 8
ZA - Sudafrica 8
CZ - Repubblica Ceca 6
IR - Iran 6
PK - Pakistan 6
EC - Ecuador 4
EG - Egitto 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CL - Cile 3
CO - Colombia 3
DO - Repubblica Dominicana 3
ID - Indonesia 3
KE - Kenya 3
TN - Tunisia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BE - Belgio 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
IL - Israele 2
JM - Giamaica 2
KR - Corea 2
KZ - Kazakistan 2
MA - Marocco 2
RS - Serbia 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
MY - Malesia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
SZ - Regno dello Swaziland 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.510
Città #
Singapore 592
San Jose 372
Chandler 252
Ashburn 240
Dublin 228
Jacksonville 209
Beijing 148
Dallas 121
Princeton 100
Dearborn 98
Southend 88
Council Bluffs 84
Santa Clara 81
Izmir 79
Los Angeles 77
Nanjing 63
The Dalles 63
Ho Chi Minh City 54
Hanoi 51
New York 49
Munich 47
Altamura 45
Ann Arbor 34
Wilmington 34
Cambridge 29
São Paulo 29
Chieti 26
Orem 24
Hong Kong 23
Redondo Beach 23
Vienna 23
Seattle 22
Moscow 21
Boardman 20
Buffalo 19
Nanchang 18
Tongling 18
Warsaw 17
Denver 16
Dong Ket 16
Pescara 16
Washington 15
Brooklyn 14
Houston 14
Montreal 14
Rome 13
Chennai 12
Gothenburg 12
Hebei 12
Hefei 12
Helsinki 12
Kunming 12
Manchester 12
Milan 12
Poplar 12
Toronto 12
Lappeenranta 11
Stockholm 11
Turku 11
Woodbridge 11
London 10
Shenyang 10
Tokyo 10
Atlanta 9
Phoenix 9
Augusta 8
Leawood 8
Nuremberg 8
Rio Saliceto 8
San Francisco 8
Tianjin 8
Ankara 7
Baghdad 7
Da Nang 7
Frankfurt am Main 7
Grevenbroich 7
Johannesburg 7
Monmouth Junction 7
San Mateo 7
St Louis 7
Brasília 6
Haiphong 6
Jinan 6
Mexico City 6
Norwalk 6
Perugia 6
Amsterdam 5
Brno 5
Hangzhou 5
Palermo 5
Querétaro 5
Vilnius 5
Zhengzhou 5
Biên Hòa 4
Changchun 4
Charlotte 4
Fairfield 4
Falls Church 4
Fuzhou 4
Goiânia 4
Totale 4.061
Nome #
Impact of migraine on fibromyalgia symptoms 223
Co-occurrence of pain syndromes 177
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 166
Cardiovascular risk in non-alcoholic fatty liver disease: Mechanisms and therapeutic implications 162
Use of Contrast-enhanced ultrasound (CEUS) in systemic mastocytosis. Report of two cases 150
Sarcoidosis: Old certainties and new perspectives [La sarcoidosi: Vecchie certezze e nuove prospettive] 147
Acute acalculous cholecystitis and cardiovascular disease: a land of confusion 145
New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters? 143
Laparoscopic Cholecystectomy for Gallbladder Calculosis in Fibromyalgia Patients: Impact on Musculoskeletal Pain, Somatic Hyperalgesia and Central Sensitization. 141
Use of Nonsteroidal Anti-Inflammatory Drugs for Symptomatic Treatment of Episodic Headache 138
microRNA profiling in atherosclerosis, diabetes, and migraine 138
Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution 137
Aliased Flow Signal Planimetry by Cardiovascular Magnetic Resonance Imaging for Grading Aortic Stenosis Severity: A Prospective Pilot Study 133
Extrapulmonary sarcoidosis: A chameleon disease at imaging 130
Hepatic artery resistive index as surrogate marker for fibrosis progression in NAFLD patients: A clinical perspective 124
Multifactorial headache in patient with chorio-retinal tuberculosis granuloma 123
Cardiovascular Morbidity and Mortality Related to Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis 122
Immunopathogenesis of sarcoidosis and risk of malignancy: a lost truth? 119
Clinical Features and Diagnosis of Cardiac Sarcoidosis 119
18F-FDG PET-CT Imaging in Sarcoidosis Molecular Mechanisms and Applications 119
Sonographic assessment of a suspected biloma: a case report and review of the literature. 118
Challenges in the diagnosis and treatment of neurosarcoidosis 118
An unusual case of urine bag discoloration 116
Teaching neuroimages: a dangerous complication of spontaneous intracranial hypotension 115
Athlete’s Heart: Diagnostic Challenges and Future Perspectives 115
Chest Imaging of Patients with Sarcoidosis and SARS-CoV-2 Infection. Current Evidence and Clinical Perspectives 115
Correlation between Migraine Severity and Cholesterol Levels 113
Pitfalls of contrast-enhanced ultrasound (CEUS) in the diagnosis of splenic sarcoidosis 112
Ultrasound imaging of abdominal sarcoidosis: State of the art 111
NSAIDs for symptomatic treatment of headache 110
Can ultrasound give valuable clues in the diagnosis of bile leakage? 109
Risk factors and current management of venous thromboembolism in patients with primary immune thrombocytopenic purpura 109
Approach to COVID-19 in older adults and indications for improving the outcomes 109
Muscle pain sensitivity in hypertensive patients with and without chronic pain 108
Severe non-traumatic bleeding, the answer is not in the blood 105
Predictors of Mortality and Cardiovascular Outcome at 6 Months after Hospitalization for COVID-19 102
Nonalcoholic fatty liver disease and cardiovascular disease phenotypes 101
Prognostic significance of noncardiac syncope in the general population: A systematic review and meta-analysis 100
Common Clinical and Molecular Pathways between Migraine and Sarcoidosis 99
Gallbladder infection by trematodes 99
CT Findings in Pulmonary and Abdominal Sarcoidosis. Implications for Diagnosis and Classification 99
Authors’ Reply to Kindermann et al.’s Comment on: “Athlete’s Heart: Diagnostic Challenges and Future Perspectives” 99
Emphysematous pancreatitis associated with penetrating duodenal ulcer 96
Management of hyperuricemia and gout in obese patients undergoing bariatric surgery 96
Sarcoidosis and COVID-19: At the Cross-Road between Immunopathology and Clinical Manifestation 93
Lp(a) and cardiovascular risk: Investigating the hidden side of the moon 92
Splenic sarcoidosis remains a diagnostic challenge. 90
A highly-detailed anatomical study of left atrial auricle as revealed by in-vivo computed tomography 89
Heterogeneous delayed enhancement of the liver after administration of ultrasound contrast agents: are we sure that it is a harmless phenomenon? 89
Pain thresholds in women with chronic pelvic pain 88
Pain from Internal Organs and Headache: The Challenge of Comorbidity 87
Clinical and Cardiovascular Magnetic Resonance Imaging Features of Cardiac Amyloidosis 86
Effects of topical vs injection treatment of cervical myofascial trigger points on headache symptoms in migraine patients: a retrospective analysis 81
Neoangiogenesis is reduced in chronic tendinopathies of type II diabetic patients 80
Splenic involvement in sarcoidosis mimicking hypoechoic metastases in colon cancer 78
Ultrasound assessment of SARS-CoV-2 pneumonia: a literature review for the primary care physician 69
Long COVID and especially headache syndromes 67
Management Issues of Sarcoidosis in the Time of Coronavirus Disease 2019 65
New Therapeutic Options for Migraine 56
Thromboembolic and bleeding risk in cardiac amyloidosis 55
Smart aging: integrating AI into elderly healthcare 53
URO-RESIST: A Real-World Retrospective Study on Multidrug-Resistant Sepsis with Urinary Tract Infection, Clinical Predictors, Inflammatory Biomarkers, and Patient Outcomes 33
Gut–Heart Axis and Infective Endocarditis: How Microbiota Dysbiosis Shapes Cardiovascular Risk and Infection Susceptibility 11
Totale 6.792
Categoria #
all - tutte 27.766
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.766


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 0 0 0 0 0 0 24
2021/2022282 4 6 7 57 24 6 4 11 31 16 38 78
2022/2023767 67 143 60 62 58 140 43 64 88 13 18 11
2023/2024446 24 10 37 17 53 126 104 33 1 14 1 26
2024/20251.124 55 240 209 18 31 57 26 39 124 75 123 127
2025/20262.586 204 66 237 299 294 163 427 157 262 260 137 80
Totale 6.792